Danaher upgraded to Buy at Stifel on top-line growth opportunities

by
Contributor since / Followers
2 days ago
Team of Research Scientists Working On Computer, with Medical Equipment, Analyzing Blood and Genetic Material Samples with Special Machines in the Modern Laboratory.

gorodenkoff/iStock via Getty Images

  • Danaher (NYSE:DHR) was upgraded to Buy from Hold at Stifel as it believes the company’s new cost savings actions could boost top-line growth.
  • Stock is up 2% in morning trade.
  • Stifel analysts said that while the 2025 guide was underwhelming, it
Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *